MicroPort NeuroTech Limited (2172.HK)
HKD 8.88
(-2.31%)
HKD 8.88
(-2.31%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 221.6 Million CNY | 39.4% |
| 2022 | 176.74 Million CNY | 79.77% |
| 2021 | 108.82 Million CNY | 44.42% |
| 2020 | 68.23 Million CNY | 7.2% |
| 2019 | 63.5 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 95.71 Million HKD | -33.17% |
| 2024 Q2 | 94.9 Million HKD | -0.15% |
| 2023 Q1 | 45.63 Million HKD | -65.34% |
| 2023 FY | - CNY | 39.4% |
| 2023 Q4 | 155.1 Million HKD | 81.63% |
| 2023 Q3 | 85.39 Million HKD | -18.19% |
| 2023 Q2 | 104.39 Million HKD | 128.74% |
| 2022 Q4 | 131.65 Million HKD | 0.0% |
| 2022 Q2 | 63.78 Million HKD | 0.0% |
| 2022 FY | - CNY | 79.77% |
| 2021 FY | - CNY | 44.42% |
| 2020 FY | - CNY | 7.2% |
| 2019 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 104.43 Million HKD | -112.198% |